PTC Therapeutics (PTCT) Tops Q1 EPS by 4c; Says Actively Pursuing Global Translarna Approvals in DMD
Go back to PTC Therapeutics (PTCT) Tops Q1 EPS by 4c; Says Actively Pursuing Global Translarna Approvals in DMD| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 71.70 -0.27 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.97 | 52 Week High | $35.40 | |||
| Open | $71.58 | 52 Week Low | $4.03 | |||
| Day High | $72.13 | P/E | 7.63 | |||
| Day Low | $70.85 | EPS | $9.40 | |||
| Volume | 564,331 | |||||
